Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
XOMA
XOMA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
XOMA News
XOMA Reports Q4 Earnings Exceeding Expectations
Mar 18 2026
seekingalpha
XOMA to Announce FY Earnings on March 18
Mar 17 2026
seekingalpha
CytomX Therapeutics Stock Surges 44.23% Following Positive Phase 1 Data
Mar 16 2026
Fool
CytomX Therapeutics Stock Soars 44.23% After Positive Phase 1 Data
Mar 16 2026
NASDAQ.COM
XOMA Royalty Completes Acquisition of Generation Bio
Feb 09 2026
Newsfilter
XOMA Corporation Under Investigation, Stock Plummets 22.76%
Jan 20 2026
Globenewswire
XOMA Corporation Under Investigation, Stock Plummets 22.76%
Jan 13 2026
Globenewswire
XOMA Royalty CFO Thomas Burns Resigns, Jeffrey Trigilio Appointed
Jan 12 2026
NASDAQ.COM
XOMA Royalty CFO Thomas Burns Steps Down, Jeffrey Trigilio Appointed
Jan 12 2026
Globenewswire
XOMA Shares Plunge 22.76% Following Phase 3 Study Failure
Jan 08 2026
PRnewswire
XOMA Shares Plunge 22.76% Following Phase 3 Study Failure
Dec 30 2025
Globenewswire
Weekly Update: CYTK Receives Initial FDA Approval, INSM Concludes Rhinosinusitis Research, XOMA Purchases GBIO
Dec 20 2025
NASDAQ.COM
XOMA Royalty Acquires Generation Bio at $4.2913 per Share
Dec 15 2025
Globenewswire
XOMA Royalty Acquires Generation Bio at $4.2913 per Share
Dec 15 2025
Newsfilter
XOMA Royalty Set to Purchase Generation Bio
Dec 15 2025
SeekingAlpha
What’s Causing the Decline of XOMA Royalty Stock on Thursday?
Dec 11 2025
Benzinga
Show More News
